• 主题
高级搜索  >
历史搜索 清空历史
首页> 美国卫生研究院文献>Journal of Healthcare Leadership >Collaborative public–private initiatives targeting multidrug-resistant tuberculosis (MDR-TB) supported by the Lilly MDR-TB Partnership: experiences in 2012–2016
【2h】

Collaborative public–private initiatives targeting multidrug-resistant tuberculosis (MDR-TB) supported by the Lilly MDR-TB Partnership: experiences in 2012–2016

机译：礼来耐多药结核病伙伴关系支持的针对耐多药结核病的公共-私营合作倡议：2012-2016年的经验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Since 2003, the Lilly Foundation has supported the noncommercial Lilly MDR-TB Partnership, which involves more than 45 local, national, global, and nongovernmental organizations and governments. The aim of the Lilly MDR-TB Partnership is to achieve significant global impact on multidrug-resistant tuberculosis (MDR-TB) by addressing a series of important local health care needs in highly affected countries: China, India, Russia, and South Africa. The main focus of activities during 2012–2016 was on community needs in primary care. Supported projects seek to make meaningful and measurable progress toward global and national TB objectives. The partnership programs share an overall conceptual approach known as “research, report, advocate”, based on the piloting of novel approaches on a small scale, with outcomes assessed at early stages. The results are analyzed and communicated to governments, health-policy experts, and local and national stakeholders, including those in other countries facing similar MDR-TB challenges. For successful, cost-effective initiatives, the analysis is used as support when advocating for the scaling up of initiatives to regional or national levels. This article discusses representative examples of projects supported by the Lilly MDR-TB Partnership in the time period 2012–2016. The examples illustrate the potential for globally informed, locally designed primary-care collaborations to strengthen health care systems and support TB policies and offer observations to inform future health care public–private partnerships.
机译：自2003年以来，礼来基金会一直支持非商业性的礼来耐多药结核病伙伴关系，该伙伴关系涉及45个以上的地方，国家，全球和非政府组织和政府。礼来耐多药结核病伙伴关系的目标是通过满足高度受影响的国家（中国，印度，俄罗斯和南非）的一系列重要的当地卫生保健需求，来实现对耐多药结核病的重大全球影响。 2012-2016年期间活动的主要重点是初级保健中的社区需求。受支持的项目力求在实现全球和国家结核病目标方面取得有意义且可衡量的进展。伙伴关系方案基于小规模新颖方法的试点，共享一种称为“研究，报告，倡导者”的总体概念方法，并在早期阶段评估结果。分析结果并将其传达给政府，卫生政策专家以及地方和国家利益相关者，包括面临类似耐多药结核病挑战的其他国家的利益相关者。对于成功的，具有成本效益的计划，在提倡将计划扩大到区域或国家级别时，该分析将用作支持。本文讨论了礼来耐多药结核病伙伴关系在2012-2016年期间支持的项目的代表性示例。这些例子说明了在全球范围内进行知情的，由当地设计的初级保健合作以加强卫生保健系统和支持结核病政策的潜力，并提供意见以为将来的卫生保健公私伙伴关系提供依据。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号